GC Holdings Sells Curevo Stake for 459.9B KRW
녹십자홀딩스
005250
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
54%n=162
Risk-adjusted indicator based on 162 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Disposal Amount: 459,926,415,106 KRW
- • Number of Shares Disposed: 21,075,336 Shares
- • Disposal Amount to Subsidiary's Total Assets: 15.48%
- • Disposal Amount to Parent's Consolidated Total Assets: 11.30% (459.9B KRW / 4,069.17B KRW)
- • Curevo's 2025 Net Loss: 63,332M KRW
AI Analysis Summary
Green Cross Holdings' subsidiary, GC Biopharma Corp., decided to dispose of its entire stake in Curevo, Inc., a US-based medical R&D company, to Eli Lilly and Company for 459.9 billion KRW. This disposal, representing 15.48% of GC Biopharma's total assets and approximately 11.30% of Green Cross Holdings' consolidated total assets, aims to secure funds for new business investments. Curevo, Inc. reported a net loss of 63.3 billion KRW in 2025. The transaction is structured with upfront and milestone payments, with the disposal expected to be completed by August 24, 2026. This move is expected to improve the financial structure and provide capital for future growth initiatives.
How This Event Is Evaluated
Treasury Share Disposal Evaluation
Treasury share disposal events are evaluated by assessing supply impact, disposal method, and stated purpose.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Disposal size relative to shares outstanding
- Disposal method and timing
- Stated purpose (funding, compensation, etc.)
- Dilution / supply impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.